VanEck Associates’s MEDIVATION, INC. MDVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-403,749
Closed -$24.3M 899
2016
Q2
$24.3M Sell
403,749
-81,893
-17% -$4.64M 0.12% 99
2016
Q1
$22.3M Sell
485,642
-2,621
-0.5% -$95.1K 0.15% 118
2015
Q4
$23.6M Buy
488,263
+62,988
+15% +$2.72M 0.19% 123
2015
Q3
$18.1M Sell
425,275
-25,687
-6% -$1.27M 0.14% 134
2015
Q2
$25.8M Sell
450,962
-37,998
-8% -$2.34M 0.15% 128
2015
Q1
$31.6M Buy
488,960
+84,774
+21% +$4.86M 0.18% 118
2014
Q4
$20.1M Buy
404,186
+27,188
+7% +$1.41M 0.13% 139
2014
Q3
$18.6M Sell
376,998
-5,318
-1% -$226K 0.1% 151
2014
Q2
$14.7M Sell
382,316
-61,124
-14% -$2.06M 0.07% 173
2014
Q1
$14.3M Buy
443,440
+37,660
+9% +$1.39M 0.07% 164
2013
Q4
$12.9M Buy
405,780
+49,100
+14% +$1.48M 0.07% 166
2013
Q3
$10.7M Buy
356,680
+14,364
+4% +$410K 0.05% 170
2013
Q2
$8.42M Buy
+342,316
New +$8.61M 0.05% 177

Other funds holding MDVN

VanEck Associates's MDVN Position: Q3 2016 in Review

VanEck Associates sold out of MEDIVATION, INC. (MDVN) in Q3 2016, closing a stake of 403,749 shares — an estimated $24.3M sold.

VanEck Associates first reported a position in MDVN in Q2 2013 and held it in 13 quarters. The position peaked at $31.6M in Q1 2015. 53 funds tracked by Wall St. Rank hold MDVN as of Q3 2016.

  • VanEck Associates reported no remaining MEDIVATION, INC. position as of Q3 2016 after selling out during the quarter.
  • VanEck Associates sold 403,749 MEDIVATION, INC. shares in Q3 2016, an estimated $24.3M.
  • VanEck Associates first reported a position in MEDIVATION, INC. in Q2 2013 and held it in 13 quarters.
  • VanEck Associates's MEDIVATION, INC. position peaked at $31.6M in Q1 2015.
  • 53 funds tracked by Wall St. Rank held MEDIVATION, INC. as of Q3 2016.

Based on VanEck Associates's 13F filing for Q3 2016, filed 14 Nov 2016.